Latest Insmed News & Updates

See the latest news and media coverage for Insmed. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Insmed

Biopharmaceutical company developing therapies for serious diseases

insmed.com
Headquarters
Bridgewater Township, United States
Company type
Public company
Number of employees
1,700–5,000
Industry
Pharmaceuticals

Last updated

Latest news about Insmed

In short: Insmed achieved regulatory approvals for Brinsupri and reported positive clinical data for its TPIP and ARIKAYCE respiratory programs.

Company announcements

Insmed

Insmed reports Q1 2026 financial results

Total revenues reach $306M with BRINSUPRI at $207.9M and ARIKAYCE at $98.1M. Reiterates 2026 guidance. ENCORE study meets endpoints; PALM-PAH initiated.

Insmed

Insmed presents respiratory portfolio data at ATS 2026

Includes late-breaking ARIKAYCE Phase 3b ENCORE results, BRINSUPRI analysis, TPIP pharmacokinetics, and grants ATS for bronchiectasis diagnosis.

Unlock all announcements with a

Media coverage

Investing.com

BMO initiates Insmed stock with outperform rating on respiratory franchise potential By Investing.com

BMO initiates Insmed stock with outperform rating on respiratory franchise potential...

Unlock all articles with a

Never miss news about Insmed

Track Insmed and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Insmed competitors & trending companies

Browse news for competitors to Insmed and other trending companies.